Companies: 10,795     total market cap: A$199.350 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Regulus Therapeutics
RGLS
#7079
Rank
A$0.78 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
A$11.35
Share price
0.00%
Change (1 day)
376.52%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2025 (TTM): -A$72.73 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$64.24 Million a decrease over its 2023 earnings that were of -A$40.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$72.73 Million13.21%
2024 -A$64.24 Million56.97%
2023 -A$40.93 Million6.51%
2022 -A$38.43 Million2.53%
2021 -A$37.48 Million93.59%
2020 -A$19.36 Million-15.41%
2019 -A$22.89 Million-64.46%
2018 -A$64.39 Million-33.26%
2017 -A$96.47 Million-13.98%
2016 -A$0.12 Billion44.77%
2015 -A$77.47 Million-1.63%
2014 -A$78.76 Million203.6%
2013 -A$25.94 Million8.65%
2012 -A$23.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$10.70 B-16,333.32%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$2.16 B-3,381.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.96 B-19,767.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.61 B-29,845.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$13.75 B-20,964.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-A$0.16 Billion 129.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion 148.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.80 B-1,313.98%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com